Biologics in Pediatric Rheumatology: Quo Vadis?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s11926-016-0593-9.pdf
Reference42 articles.
1. Barnes MG, Grom AA, Thompson SD, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(7):2102–12. doi: 10.1002/art.24601 .
2. Mangge H, Kenzian H, Gallistl S. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum. 1995;38(2):211–20.
3. Berard RA, Laxer RM. Etanercept (enbrel) in the treatment of juvenile idiopathic arthritis. Expert Opin Biol Ther. 2013;13(11):1623–30. doi: 10.1517/14712598.2013.840580 .
4. Ungar WJ, Costa V, Burnett HF, et al. The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: a systematic review. Semin Arthritis Rheum. 2013;42(6):597–618. doi: 10.1016/j.semarthrit.2012.10.006 .
5. Guzman J, Kiem O, Tucker LB, et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Ann Rheum Dis. 2015;74(10):1854–60. doi: 10.1136/annrheumdis-2014-205372 . This is one of the few articles that discusses outcomes in the era of DMARDs.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How Safe Are Biological Agents in Pediatric Rheumatology?;Turkish Archives of Pediatrics;2024-03-01
2. AB1441 CLINICAL CHARACTERISTICS OF PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES UNDER TREATMENT WITH BIOLOGICAL THERAPY: INFORMATION FROM BIOBADAMEX;Scientific Abstracts;2023-05-30
3. Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis;Frontiers in Pediatrics;2022-06-21
4. Temporomandibular joint involvement in children with juvenile idiopathic arthritis—Symptoms, clinical signs and radiographic findings;Journal of Oral Rehabilitation;2021-10-27
5. Biologic medicine inclusion in 138 national essential medicines lists;Pediatric Rheumatology;2021-09-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3